Risk and protective factors for sporadic Alzheimer's disease

Acta Virologica

Volumn 51, Issue 4, 2007, Pages 205-222

  Stozicka Z ^a   Zilka N ^a   Novak M ^a  

^a INSTITUTE OF NEUROIMMUNOLOGY   (Slovakia)

Author keywords

Alzheimer's disease; Apolipoprotein E; Hypertension; Inflammation; Risk factors

Indexed keywords

ABC TRANSPORTER A1; ALPHA 1 ANTICHYMOTRYPSIN; AMYLOID; APOLIPOPROTEIN E; BRAIN DERIVED NEUROTROPHIC FACTOR; CHOLESTEROL 24 HYDROXYLASE; CHOLESTEROL 25 HYDROXYLASE; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; CYSTATIN C; DIPEPTIDYL CARBOXYPEPTIDASE; ESTROGEN RECEPTOR ALPHA; HOMOCYSTEINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULINASE; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; LEUKOCYTE ANTIGEN; LIPOPROTEIN LIPASE; MICROTUBULE ASSOCIATED PROTEIN; NICASTRIN; NICOTINIC RECEPTOR BETA2; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; OXYGENASE; SEX HORMONE; TAU PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; CHOLESTEROL METABOLISM; CHRONIC STRESS; CIGARETTE SMOKING; CLINICAL TRIAL; DIABETES MELLITUS; DISEASE COURSE; DISEASE PREDISPOSITION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; GENE INTERACTION; GENETIC RISK; GENETIC VARIABILITY; HEAD INJURY; HISTOPATHOLOGY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIPID METABOLISM; MENTAL PERFORMANCE; NONHUMAN; OBESITY; OSTEOARTHRITIS; PHYSICAL ACTIVITY; PLASTICITY; PREVALENCE; PROPHYLAXIS; PROTEIN METABOLISM; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SOCIAL BEHAVIOR; SOCIAL INTERACTION; VIRUS INFECTION; VITAMIN SUPPLEMENTATION; GENETICS;

ALZHEIMER DISEASE; APOLIPOPROTEINS E; HUMANS; RISK FACTORS;

EID: 41649095537     PISSN: 0001723X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (190)

1. Aggarwal NT, Bienias JL, Bennett DA, Wilson RS, Morris MC, Schneider JA, Shah RC, Evans DA (2006): The relation of cigarette smoking to incident Alzheimer's disease in a biracial urban community population. Neuroepidemiology 26, 140-146.
2. Alvarez R, Alvarez V, Lahoz CH, Martínez C, Peña J, Sánchez JM, Guisasola LM, Salas-Puig J, Morís G, Vidal JA, Ribacoba R, Menes BB, Uría D, Coto E (1999): Angiotensin converting enzyme and endothelial nitric oxide synthase DNA polymorphisms and late onset Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 67, 733-736.
3. Alvarez V, Mata IF, Gonzales P, Lahoz CH, Martinez C, Pena J, Guisasola LM, Coto E (2002): Association between the TNFα-308 A/G Polymorphism and the Onset-Age of Alzheimer Disease. Am. J. Med. Genet. (Neuropsychiatric Genetics) 114, 574-577. (Pubitemid 34680588)
4. Andersen OM, Reiche J, Schmidt V, Gotthardt M, Spoelgen R, Behlke J, von Arnim CA, Breiderhoff T, Jansen P, Wu X, Bales KR, Cappai R, Masters CL, Gliemann J, Mufson EJ, Hyman BT, Paul SM, Nykjaer A, Willnow TE (2005): Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. Proc. Natl. Acad. Sci. USA 102, 13461-13466. (Pubitemid 41420870)
5. Araria-Goumidi L, Lambert JC, Mann DM, Lendon C, Frigard B, Iwatsubo T, Cottel D, Amouyel P, Chartier-Harlin MC (2002): Association study of three polymorphisms of TGF-beta1 gene with Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 73, 62-64. (Pubitemid 34713015)
6. Arendt T (2002): Dysregulation of neuronal differentiation and cell cycle control in Alzheimer's disease, J. Neural Transm. Suppl., 77-85. (Pubitemid 37046655)
7. Arendt T, Bruckner MK, Gertz JH, Marcova J (1998): Cortical distribution of neurofibrillary tangles in Alzheimer's disease matches the pattern of neurons that retain their capacity of plastic remodelling in the adult brain. Neuroscience 83, 991-1002. (Pubitemid 28114194)
8. Arkin SM (2003): Student-led exercise sessions yield significant fitness gains for Alzheimer's patients. Am. J. Alzheimers Dis. Other Demen. 18, 159-170.
9. Arosio B, Trabattoni D, Galimberti L, Bucciarelli P, Fasano F, Calabresi C, Cazzullo CL, Vergani C, Annoni G, Clerici M (2004): Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease. Neurobiol. Aging 25, 1009-1015. (Pubitemid 38798062)
10. Bagnoli S, Cellini E, Tedde A, Nacmias B, Piacentini S, Bessi V, Bracco L, Sorbi S (2007): Association of IL10 promoter polymorphism in Italian Alzheimer's disease. Neurosci. Lett. 418, 262-265. (Pubitemid 46670562)
11. Baker M, Graff-Radford D, DeVrieze FW, Graff-Radford N, Petersen RC, Kokmen E, Boeve B, Myllykangas L, Polvikoski T, Sulkava R, Verkoniemmi A, Tienari P, Haltia M, Hardy J, Hutton M, Perez-Tur J (2000): No association between TAU haplotype and Alzheimer's disease in population or clinic based series or in familial disease. Neurosci. Lett. 285, 147-149. (Pubitemid 30227641)
12. Ballerini C, Nacmias B, Rombola G, Marcon G, Massacesi L, Sorbi S (1999): HLA A2 allele is associated with age at onset of Alzheimer's disease. Ann. Neurol. 45, 397-400. (Pubitemid 29120047)
13. Baum L, Chen L, Masliah E, Chan YS, Ng HK, Pang CP. (1999): Lipoprotein lipase mutations and Alzheimer's disease. Am. J. Med. Genet. 88, 136-139. (Pubitemid 29156450)
14. Beffert U, Poirier J (1996): Apolipoprotein E, plaques, tangles and cholinergic dysfunction in Alzheimer's disease. Ann. N.Y. Acad. Sci. 777, 166-174. (Pubitemid 26149184)
15. Belin AC, Björk BF, Westerlund M, Galter D, Sydow O, Lind C, Pernold K, Rosvall L, HÍkansson A, Winblad B, Nissbrandt H, Graff C, Olson L (2007): Association study of two genetic variants in mitochondrial transcription factor A (TFAM) in Alzheimer's and Parkinson's disease. Neurosci. Lett. 420, 257-262. (Pubitemid 46856016)
16. Berg L, McKeel Jr DW, Miller JP, Storandt M, Rubin EH, Morris JC, Baty J, Coats M, Norton J, Goate AM, Price JL, Gearing M, Mirra SS, Saunders AM (1998): Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch. Neurol. 55, 326-1235 (Pubitemid 28146197)
17. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE (2007): Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat. Genet. 39, 17-23. (Pubitemid 46026496)
18. Beyer K, Lao JI, Gomez M, Riutort N, Latorre P, Mate JL, Ariza A (2001): Alzheimer's disease and the cystatin C gene polymorphism: an association study. Neurosci. Lett. 315, 17-20. (Pubitemid 33049988)
19. Bian L, Yang JD, Guo TW, Sun Y, Duan SW, Chen WY, Pan YX, Feng GY, He L (2004): Insulin-degrading enzyme and Alzheimer disease: a genetic association study in the Han Chinese. Neurology 63, 241-245. (Pubitemid 38971121)
20. Blomqvist ME, Chalmers K, Andreasen N, Bogdanovic N, Wilcock GK, Cairns NJ, Feuk L, Brookes AJ, Love S, Blennow K, Kehoe PG, Prince JA (2005): Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain. Neurobiol. Aging 26, 795-802. (Pubitemid 40249481)
21. Bossy-Wetzel E, Schwarzenbacher L, Lipton SA (2004): Molecular pathways to neurodegenration. Nat. Med. 10, (Suppl.) S2-S9.
22. Bourre JM (2006a): Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients. J. Nutr. Health Aging 10, 377-385. (Pubitemid 44845348)
23. Bourre JM (2006b): Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 2: macronutrients. J. Nutr. Health Aging 10, 386-399. (Pubitemid 44845349)
24. Breteler M (2000): Vascular risk factors in Alzheimer's disease: An epidemiologic perspective. Neurobiol. Aging 21, 153-160. (Pubitemid 30387074)
25. Bullido MJ, Aldudo J, Frank A, Coria F, Avila J, Valdivieso F (2000): A polymorphism in the tau gene associated with risk for Alzheimer's disease. Neurosci. Lett. 278, 49-52. (Pubitemid 30009894)
26. Burgos JS, Ramirez C, Sastre I, Bullido MJ, Valdivieso F (2003): ApoE4 is more efficient than E3 in brain access by herpes simplex virus type 1. Neuroreport 14, 1825-1827. (Pubitemid 37372611)
27. Casadesus G, Atwood CS, Zhu X, Hartzler AW, Webber KM, Perry G, Bowen RL, Smith MA (2005): Evidence for the role of gonadotropin hormones in the development of Alzheimer disease. Cell. Mol. Life Sci. 62, 293-298. (Pubitemid 40379244)
28. Casadesus G, Webber KM, Atwood CS, Pappolla MA, Perry G, Bowen RL, Smith MA (2006): Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice. Biochim. Biophys. Acta 1762, 447-452. (Pubitemid 43344306)
29. Cathcart HM, Huang R, Lanham IS, Corder EH, Poduslo SE (2005): Cystatin C as a risk factor for Alzheimer disease. Neurology 64, 755-757. (Pubitemid 40261919)
30. Chu LW, Li Y, Li Z, Tang AY, Cheung BM, Leung RY, Yik PY, Jin DY, Song YQ (2007): A novel intronic polymorphism of ABCA1 gene reveals risk for sporadic Alzheimer's disease in Chinese. Am. J. Med. Genet. B. Neuropsychiatr. Genet. (in press).
31. Chuo LJ, Sheu WH, Pai MC, Kuo YM (2007): Genotype and plasma concentration of cystatin C in patients with late-onset Alzheimer disease. Dement. Geriatr. Cogn. Disord. 23, 251-257.
32. Colucci M, Cammarata S, Assini A, Croce R, Clerici F, Novello C, Mazzella L, Dagnino N, Mariani C, Tanganelli P (2006): The number of pregnancies is a risk factor for Alzheimer's disease. Eur. J. Neurol. 13, 1374-1377. (Pubitemid 44736650)
33. Combarros O, Sánchez-Guerra M, Llorca J, Alvarez-Arcaya A, Berciano J, Peńa N, Fernández-Viadero C (2000): Polymorphism at codon 129 of the prion protein gene is not associated with sporadic AD. Neurology 55, 593-595. (Pubitemid 30647267)
34. Confaloni A., Terreni L, Piscopo P, Crestini A, Campeggi LM, Frigerio CS, Blotta I, Perri M, Di Natale M, Maletta R, Marcon G, Franceschi M, Bruni AC, Forloni G, Cantafora A (2003): Nicastrin gene in familial and sporadic Alzheimer's disease. Neuroscience Letters 353, 61-65. (Pubitemid 37464620)
35. Cook LJ, Ho LW, Tazlor AE, Brazne C, Evans JG, Xuereb J, Cairns NJ, Pritchard A, Lemmon H, Mann D, St Clair D, Turic D, Hollingworth P, Moore PJ, Jehu L, Archer N, Walter S, Foy C, Edmondson A, Powel J, Lovestone S, Owen MJ, Williams J, Lendon C, Rubinsztein DC (2004): Candidate gene association studies of the α4 (CHRNA4) and ß2 (CHRNB2) neuronal nicotinic acetylcholine receptor subunit genes in Alzheimer's disease. Neurosci. Lett. 358, 142-146.
36. Coppede F, Mancuso M, Siciliano G, Migliore L, Murri L (2006): Genes and the environment in neurodegeneration. Biosci. Rep. 26, 341-367.
37. Corbo RM, Gambina G, Ruggeri M, Scacchi R (2006): Association of estrogen receptor alpha (ESR1) PvuII and XbaI polymorphisms with sporadic Alzheimer's disease and their effect on apolipoprotein E concentrations. Dement. Geriatr. Cogn. Disord. 22, 67-72. (Pubitemid 43909831)
38. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell Jr PC, Rimmler JB, Locke PA, Conneally PM, Schmader KE, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1994): Protective effect of apolipo-protein E type 2 allele for late onset Alzheimer disease. Nat. Genet. 7, 180-184.
39. Curran M, Middleton D, Edwardson J, Perry R, McKeith I, Morris C, Neill D (1997): HLA-DR antigens associated with major genetic risk for late-onset Alzheimer's disease. Neuroreport 8, 1467-1469. (Pubitemid 27242556)
40. Desai P, Nebes R, DeKosky ST, Kamboh MI (2005): Investigation of the effect of brain-derived neurotrophic factor (BDNF) polymorphisms on the risk of late-onset Alzheimer's disease (AD) and quantitative measures of AD progression. Neurosci. Lett. 379, 229-234. (Pubitemid 40544540)
41. Dickson MR, Perry RT, Wiener H, Go RC (2005): Association studies of transforming growth factor-beta 1 and Alzheimer's disease. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 139, 38-41. (Pubitemid 41552295)
42. Eikelenboom P, Veerhuis R, Scheper W, Rozemuller AJM, van Gool WA, Hoozemans JJM (2006): The significance of neuroinflammation in understanding Alzheimer's disease. J. Neural. Transm. 113, 1685-1695. (Pubitemid 44657664)
43. Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ, Hebert LE, Hennekens CH, Taylor JO (1989): Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA 262, 2551-2556.
44. Farkas E, De Vos RAI, Jansen Steur ENH, Luiten PGM (2000): Are Alzheimer's disease, hypertension and cerebrocapillary damage related? Neurobiol. Aging 21, 235-243. (Pubitemid 30387082)
45. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM (1997): Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. J. Am. Med. Assoc. 278, 1349-1356.
46. Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, Eckman CB, Tanzi RE, Selkoe DJ, Guenette S (2003): Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc. Natl. Acad. Sci. USA 100, 4162-4167. (Pubitemid 36418174)
47. Ferenčík M, Novák M, Rovensky J, Rybar I (2001): Alzheimer's disease, inflammation and non-steroidal anti-inflammatory drugs. Bratisl. Lek. Listy. 102, 123-132.
48. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M (2005): Global prevalence of dementia: a Delphi consensus study. Lancet 366, 2112-2117. (Pubitemid 41797645)
49. Fidani L, Compton D, Hardy J, Petersen RC, Tangalos E, Mirtsou V, Goulas A, Wavrant De Vrieze F (2002): No association between the lipoprotein lipase S447X polymprphism and Alzheimer's disease. Neurosci. Lett. 322, 192-194. (Pubitemid 34230551)
50. Fishel MA, Watson GS, Montine TJ, Wang Q, Green PS, Kulstad JJ, Cook DG, Peskind ER, Baker LD, Goldgaber D, Nie W, Asthana S, Plymate SR, Schwartz MW, Craft S (2005): Hyperinsulinemia provokes synchronous increases in central inflammation and beta-amyloid in normal adults. Arch. Neurol. 62, 1539-1544. (Pubitemid 41434558)
51. Freitag MH, Peila R, Masaki K, Petrovich H, Ross GW, White LR, Launer LJ (2006): Midlife pulse pressure and incidence of dementia - the Honolulu-Asia Aging Study. Stroke 37, 33-37. (Pubitemid 43732044)
52. Freund-Levi Y, Eriksdotter-Jönhagen M, Cederholm T, Basun, Faxén-Irving G, Garlind A, Vedin I, Vessby B, Wahlund LO, Palmblad J (2006): Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch. Neurol. 63, 1402-1408. (Pubitemid 44547551)
53. Fung HC, Chen CM, Wu YR, Hsu WC, Ro LS, Lin JC, Chang KH, Wang HK, Lin SJ, Chan H, Lin YY, Wei SL, Hsu Y, Hwang JC, Tung LC, Lee-Chen GJ (2005): Heat shock protein 70 and tumor necrosis factor alpha in Taiwanese patients with dementia. Dement. Geriatr. Cogn. Disord. 20, 1-7. (Pubitemid 40981171)
54. Gacia M, Safranow K, Styczynska M, Jakubowska K, Peplonska B, Chodakowska-Zebrowska M, Przekop I, Slowik A, Golanska E, Hulas-Bigoszewska K, Chlubek D, Religa D, Zekanowski C, Barcikowska M (2006): Prion protein gene M129 allele is a risk factor for Alzheimer's disease. J. Neural Transm. 113, 1747-1751. (Pubitemid 44657670)
55. Goddard KA, Olson JM, Payami H, van der Voet M, Kuivaniemi H, Tromp G (2004): Evidence of linkage and association on chromosome 20 for late-onset Alzheimer disease. Neurogenetics 5, 121-128. (Pubitemid 38828672)
56. Golanska E, Hulas-Bigoszewska K, Rutkiewicz E, Styczynska M, Peplonska B, Barcikowska M, Bratosiewicz-Wasik J, Liberski PP (2004): Polymorphisms within the prion (PrP) and prion-like protein (Doppel) genes in AD. Neurology 62, 313-315. (Pubitemid 38167150)
57. Gomez-Pinilla F (2007): The influences of diet and exercise on mental health through hormesis. Aging Res. Rev. (in press).
58. Granon S, Faure P, Changeux JP (2003): Executive and social behaviors under nicotinic receptor regulation. Proc. Natl. Acad. Sci. USA 100, 9596-9601. (Pubitemid 37033973)
59. Grimaldi LM, Casadei VM, Ferri C, Veglia F, Licastro F, Annoni G, Biunno I, De Bellis G, Sorbi S, Mariani C, Canal N, Griffin WS, Franceschi M (2000): Association of earlyonset Alzheimer's disease with an interleukin-1alpha gene polymorphism. Ann. Neurol. 47, 361-365. (Pubitemid 30141846)
60. Grossman H (2003): Does diabetes protect or provoke Alzheimer's disease? Insights into the pathology and future treatment of Alzheimer's disease. CNS Spectr. 8, 815-823.
61. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI (1986): Abnormal phosphorylation of the microtubule-associated protein tau in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. USA 83, 4913-4917.
62. Gunstad J, Paul RH, Cohen RA, Tate DF, Gordon E (2006): Obesity is associated with memory deficits in young and middle-aged adults. Eat. Weight Disord. 11, e15-19. (Pubitemid 44073003)
63. Gunstad J, Paul RH, Cohen RA, Tate DF, Spitznagel MB, Gordon E (2007): Elevated body mass index is associated with executive dysfunction in otherwise healthy adults. Compr. Psychiatry 48, 57-61. (Pubitemid 44826976)
64. Günther C, von Hadeln K, Müller-Thomsen T, Alberici A, Binetti G, Hock C, Nitsch RM, Stoppe G, Reiss J, Gal A, Finckh U (2004): Possible association of mitochondrial transcription factor A (TFAM) genotype with sporadic Alzheimer disease. Neurosci. Lett. 369, 219-223. (Pubitemid 39298912)
65. Haag M (2003): Essential fatty acids and the brain. Can. J. Psychiatry 48, 195-203.
66. Hardy J, Selkoe DJ (2002): The amyloid hypothesis of Alzheimer disease: progress and problems on the road to therapeutics. Science 297, 353-356. (Pubitemid 34790756)
67. Harris JM, Cumming AM, Craddock N, St Clair D, Lendon CL (2000): Human leucocyte antigen-A2 increases risk of Alzheimer's disease but does not affect age of onset in a Scottish population. Neurosci. Lett. 294, 37-40. (Pubitemid 30762887)
68. Harrist A, Beech RD, King SL, Zanardi A, Cleary MA, Caldarone BJ, Eisch A, Zoli M, Picciotto MR (2004): Alteration of hippocampal cell proliferation in mice lacking the beta 2 subunit of the neuronal nicotinic acetylcholine receptor. Synapse 54, 200-206. (Pubitemid 39532060)
69. Hofman A, de Jong PT, van Duijn CM, Breteler MM (2006): Epidemiology of neurological diseases in elderly people: what did we learn from the Rotterdam Study? Lancet Neurol. 5, 545-550.
70. Hogervorst E, Bandelow S, Combrinck M, Smith AD (2004): Low free testosterone is an independent risk factor for Alzheimer's disease. Exp. Gerontol. 39, 1633-1639. (Pubitemid 39576135)
71. Inzitari M, Pozzi C, Rinaldi LA, Masotti G, Marchionni N, Di Bari M (2007): Cognitive and functional impairment in hypertensive brain microangiopathy. J. Neurol. Sci. 257, 166-173. (Pubitemid 46863432)
72. Ishunina TA, Swaab DF (2001): Increased expression of estrogen receptor alpha and beta in the nucleus basalis of Meynert in Alzheimer's disease. Neurobiol. Aging 22, 417-426.
73. Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA (1997): Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet 349, 241-244. (Pubitemid 27050990)
74. Jelinger KA, Paulus W, Wrocklage C, Litvan I (2001): Traumatic brain injury as a risk factor for Alzheimer disease. Comparison of two retrospective autopsy cohorts with evaluation of ApoE genotype. BMC Neurology 1, 3. (Pubitemid 38729077)
75. Kamboh MI (2004): Molecular genetics of late-onset Alzheimer's disease. Ann. Hum. Genet. 68, 381-404. (Pubitemid 39162750)
76. Kamboh MI, Minster RL, Feingold E, DeKosky ST (2006): Genetic association of ubiquilin with Alzheimer's disease and related quantitative measures. Mol. Psychiatry 11, 273-279. (Pubitemid 43316058)
77. Katzov H, Chalmers K, Palmgren J, Andreasen N, Johansson B, Cairns NJ, Gatz M, Wilcock GK, Love S, Pedersen NL, Brookes AJ, Blennow K, Kehoe PG, Prince JA (2004): Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism. Hum. Mutat. 23, 358-367. (Pubitemid 38461517)
78. Kehoe PG, Russ C, McIlory S, Williams H, Holmans P, Holmes C, Liolitsa D, Vahidassr D, Powell J, McGleenon B, Liddell M, Plomin R, Dynan K, Williams N, Neal J, Cairns NJ, Wilcock G, Passmore P, Lovestone S, Williams J, Owen MJ (1999): Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease. Nat. Genet. 21, 71-72.
79. Kehoe PG, Katzov H, Feuk L, Bennet AM, Johansson B, Wiman B, de Faire U, Cairns NJ, Wilcock GK, Brookes AJ, Blennow K, Prince JA (2003): Haplotypes extending across ACE are associated with Alzheimer's disease. Hum. Mol. Genet. 12, 859-867. (Pubitemid 36504028)
80. Ki CS, Na DL, Kim DK, Kim HJ, Kim JW (2002): Genetic association of an apolipoprotein C-I (APOC1) gene polymorphism with late-onset Alzheimer's disease. Neurosci. Lett. 319, 75-78.
81. Kivipelto M, Helkala EL, Laakso MP, Hanninen T, Hallikainen M, Alhainen K, Soininnen H, Tuomilehto J, Nissien A (2001): Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 322, 1447-1451. (Pubitemid 32575406)
82. Kramer AF, Erickson KI (2007): Capitalizing on cortical plasticity: influence of physical activity on cognition and brain function. Trends Cogn. Sci. 11, 342-348.
83. Kramer AF, Hahn S, Cohen NJ, Banich MT, McAuley E, Harrison CR, Chason J, Vakil E, Bardell L, Boileau RA, Colcombe A (1999): Ageing, fitness and neurocognitive function. Nature 400, 418-419.
84. Kravitz HM, Meyer PM, Seeman TE, Greendale GA, Sowers MR (2006): Cognitive functioning and sex steroid hormone gene polymorphisms in women at midlife. Am. J. Med. 119, S94-S102. (Pubitemid 44292108)
85. Kunugi H, Ueki A, Otsuka M, Isse K, Hirasawa H, Kato N, Nabika T, Kobayashi S, Nanko S (2001): A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer's disease. Mol. Psychiatry 6, 83-86. (Pubitemid 32096070)
86. Kuwano R, Miyashita A, Arai H, Asada T, Imagawa M, Shoji M, Higuchi S, Urakami K, Kakita A, Takahashi H, Tsukie T, Toyabe S, Akazawa K, Kanazawa I, Ihara Y (2006): Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease. Hum. Mol. Genet. 15, 2170-2182.
87. Lambeth JD (2007): Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy. Free Radic. Biol. Med. 43, 332-347.
88. Landen M, Thorsell A, Wallin A, Blennow K (1996): The apolipoprotein E allele epsilon 4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 61, 352-356. (Pubitemid 26355775)
89. Larson EB, Wang L, Bowen JD, McCormick WC, Teri L, Crane P, Kukull W (2006): Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann. Intern. Med. 144, 73-81. (Pubitemid 46768225)
90. Laurin D, Verreault R, Lindsay J, MacPherson K, Rockwood K (2001): Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch. Neurol. 58, 498-504. (Pubitemid 32217469)
91. Lazarov O, Robinson J, Tang YP, Hairston IS, Korade-Mirnics Z, Lee VM, Hersh LB, Sapolsky RM, Mirnics K, Sisodia SS (2005): Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 120, 701-713. (Pubitemid 40343081)
92. Lehmann DJ, Barnardo MC, Fuggle S, Quiroga I, Sutherland A, Warden DR, Barnetson L, Horton R, Beck S, Smith AD (2006): Replication of the association of HLA-B7 with Alzheimer's disease: a role for homozygosity? J. Neuroinflammation 3, 1-7.
93. Levi O, Jongen-Relo AL, Feldon J, Roses AD, Michaelson DM (2003): ApoE4 impairs hippocampal plasticity isoform-specifically and blocks the environmental stimulation of synaptogenesis and memory. Neurobiol. Dis. 13, 273-282. (Pubitemid 36937209)
94. Levin ED, McClernon FJ, Rezvani AH (2006): Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology 184, 523-539.
95. Li X, Rowland LP, Mitsumoto H, Przedborski S, Bird TD, Schellenberg GD, Peskind E, Johnson N, Siddique T, Mesulam MM, Weintraub S, Mastrianni JA (2005): Prion protein codon 129 genotype prevalence is altered in primary progressive aphasia. Ann. Neurol. 58, 858-864. (Pubitemid 41748288)
96. Li Y, Liu L, Barger SW, Griffin WST (2003): Interleukin-1 Mediates Pathological Effects of Microglia on Tau Phosphorylation and on Synaptophysin Synthesis in Cortical Neurons through a p38-MAPK Pathway. J. Neurosci. 23, 1605-1611. (Pubitemid 36314715)
97. Li Y, Chu LW, Chen YQ, Cheung BM, Leung RY, Yik PY, Ng KM, Mak W, Jin DY, St George-Hyslop P, Song YQ. (2006): Intron 2 (T/C) CYP46 polymorphism is associated with Alzheimer's disease in Chinese patients. Dement. Geriatr. Cogn. Disord. 22, 399-404. (Pubitemid 44726009)
98. Licastro F, Chiappelli M (2003): Brain immune responses cognitive decline and dementia: relationship with phenotype expression and genetic background. Mech. Ageing Dev. 124, 539-548. (Pubitemid 36514911)
99. Licastro F, Grimaldi LM, Bonafe M, Martina C, Olivieri F, Cavallone L, Giovanietti S, Masliah E, Franceschi C (2003): Interleukin-6 gene alleles affect the risk of Alzheimer's disease and levels of the cytokine in blood and brain. Neurobiol. Aging 24, 921-926. (Pubitemid 36962977)
100. Lin WR, Wozniak MA, Cooper RJ, Wilcock GK, Itzhaki RF (2002): Herpesviruses in brain and Alzheimer's disease. J. Pathol. 197, 395-402.
101. Lio D, Annoni G, Licastro F, Crivello A, Forte GI, Scola L, Colonna-Romano G, Candore G, Arosio B, Galimberti L, Vergani C, Caruso C (2006a): Tumor necrosis factoralpha 308A/G polymorphism is associated with age at onset of Alzheimer's disease. Mech. Ageing Dev. 127, 567-571.
102. Lio D, Scola L, Crivello A (2006b): Immunogenic markers and the sporadic Alzheimer's disease diagnostic knot. ASHI Quarterly Fourth Quarter 2006, 104-106.
103. Luckhaus C, Sand PG (2007): Estrogen Receptor 1 gene (ESR1) variants in Alzheimer's disease. Results of a metaanalysis. Aging Clin. Exp. Res. 19, 165-168. (Pubitemid 46779402)
104. Luchsinger JA, Reitz C, Patel B, Tang MX, Manly JJ, Mayeux R (2007a): Relation of diabetes to mild cognitive impairment. Arch. Neurol. 64, 570-575. (Pubitemid 46588347)
105. Luchsinger JA, Tang MX, Miller J, Green, Mayeux R (2007b): Relation of higher folate intake to lower risk of Alzheimer disease in the elderly. Arch. Neurol. 64, 86-92. (Pubitemid 46072428)
106. Luedecking EK, DeKosky ST, Mehdi H, Ganguli M, Kamboh MI (2000): Analysis of genetic polymorphisms in the transforming growth factor-beta1 gene and the risk of Alzheimer's disease. Hum. Genet. 106, 565-569. (Pubitemid 30406684)
107. Lupien SJ, de Leon M, de Santi S, Convit A, Tarshish C, Nair NP, Thakur M, McEwen BS, Hauger RL, Meaney MJ (1998): Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat. Neurosci. 1, 69-73. (Pubitemid 128652645)
108. Lye TC, Shores A (2000): Traumatic injury as a risk factor for Alzheimer's disease: A review. Neuropsychol. Rev. 10, 115-129. (Pubitemid 30480342)
109. Ma SL, Tang NL, Lam LC, Chiu HF (2006): Polymorphisms of the cholesterol 24-hydroxylase (CYP46A1) gene and the risk of Alzheimer's disease in a Chinese population. Int. Psychogeriatr. 18, 37-45.
110. Martin-Rehrmann MD, Cho HS, Rebeck GW. (2002): Lack of association of two lipoprotein lipase polymorphisms with Alzheimer's disease. Neurosci. Lett. 328, 109-112. (Pubitemid 34804723)
111. Masters CL, Beyreuther K (2006): Pathways to the discovery of the Abeta amyloid of Alzheimer's disease. J. Alzheimers Dis. 9 (3 Suppl.) 155-161. (Pubitemid 44253308)
112. Matsushita S, Arai H, Matsui T, Yuzuriha T, Urakami K, Masaki T, Higuchi S (2005): Brain-derived neurotrophic factor gene polymorphisms and Alzheimer's disease. J. Neural. Transm. 112, 703-711. (Pubitemid 40591202)
113. McGeer PL, Itagaki S, Tago H, McGeer EG (1987): Reactive microglia in patients with senile dementia of Alzheimertype are positive for the histocompatibility glycoprotein HLA-DR. Neurosci. Lett. 79, 195-200. (Pubitemid 17144469)
114. McGeer PL, McGeer EG (2007): NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies. Neurobiol. Aging 28, 639-647. (Pubitemid 46349357)
115. Minster RL, Dekosky ST, Kamboh MI (2007): No association of dynamin binding protein (DNMBP) gene SNPs and Alzheimer's disease. Neurobiol. Aging (in press).
116. Monastero R, Camarda C, Cefalu AB, Caldarella R, Camarda LK, Noto D, Averna MR, Camarda R (2005): No association between the cystatin C gene polymorphism and Alzheimer's disease: a case-control study in an Italian population. J. Alzheimers Dis. 7, 291-295. (Pubitemid 41206940)
117. Mortimer JA, Borenstein AR, Gosche KM, Snowdon DA (2005): Very early detection of Alzheimer neuropathology and the role of brain reserve in modifying its clinical expression. J. Geriatr. Psychiatry Neurol. 18, 218-223.
118. Mukherjee O, Kauwe JS, Mayo K, Morris JC, Goate AM (2007): Haplotype-based association analysis of the MAPT locus in late onset Alzheimer's disease. BMC Genet. 8, 3.
119. Myers AJ, Kaleem M, Marlowe L, Pittman AM, Lees AJ, Fung HC, Duckworth J, Leung D, Gibson A, Morris CM, de Silva R, Hardy J (2005): The H1c haplotype at the MAPT locus is associated with Alzheimer's disease. Hum. Mol. Genet. 14, 2399-2404. (Pubitemid 41418001)
120. Nagy Z, Esiri MM, Jobst KA, Johnston C, Litchfield S, Sim E, Smith AD (1995): Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease. Neuroscience 69, 757-761.
121. Narain Y, Yip A, Murphy T, Brayne C, Easton D, Evans JG, Xuereb J, Cairns N, Esiri MM, Furlong RA, Rubinsztein DC (2000): The ACE gene and Alzheimer's disease susceptibility. J. Med. Genet. 37, 695-697.
122. Novák M, Jakes R, Edwards PC, Milstein C, Wischik CM (1991): Difference between the tau protein of Alzheimer paired helical filament core and normal tau revealed by epitope analysis of monoclonal antibodies 423 and 7.51. Proc. Natl. Acad. Sci. USA 88, 5837-5841. (Pubitemid 21914841)
123. Novák M, Kabát J, Wischik CM (1993): Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament. EMBO J. 12, 365-370. (Pubitemid 23042416)
124. Ohkubo T, Sakasegawa Y, Asada T, Kinoshita T, Goto Y, Kimura H, Mizusawa H, Hachiya NS, Kaneko K (2003): Absence of association between codon 129/219 polymorphisms of the prion protein gene and Alzheimer's disease in Japan. Ann. Neurol. 54, 553-554. (Pubitemid 37176558)
125. Olsen L, Rasmussen HB, Hansen T, Bagger YZ, Tanko LB, Qin G, Christiansen C, Werge T (2006): Estrogen receptor alpha and risk for cognitive impairment in postmenopausal women. Psychiatr. Genet. 16, 85-88. (Pubitemid 44481211)
126. Orlacchio A, Kawarai T, Polidoro M, Stefani A, Orlacchio A, St George-Hyslop PH, Bernardi G (2002): Association analysis between Alzheimer's disease and the Nicastrin gene polymorphisms. Neurosci. Lett. 333, 115-118. (Pubitemid 35284898)
127. Ott A, Slooter AJ, Hofman A, van Harskamp F, Witteman JC, Van Broeckhoven C, van Duijn CM, Breteler MM (1998): Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study. Lancet 351, 1840-1843. (Pubitemid 28279707)
128. Papassotiropoulos A, Lambert JC, Wavrant-De Vrieze F, Wollmer MA, von der Kammer H, Streffer JR, Maddalena A, Huynh KD, Wolleb S, Lutjohann D, Schneider B, Thal DR, Grimaldi LM, Tsolaki M, Kapaki E, Ravid R, Konietzko U, Hegi T, Pasch T, Jung H, Braak H, Amouyel P, Rogaev EI, Hardy J, Hock C, Nitsch RM (2005): Cholesterol 25-hydroxylase on chromosome 10q is a susceptibility gene for sporadic Alzheimer's disease. Neurodegener. Dis. 2, 233-241.
129. Peavy GM, Lange KL, Salmon DP, Patterson TL, Goldman S, Gamst AC, Mills PJ, Khandrika S, Galasko D (2007): The effects of prolonged stress and APOE genotype on memory and cortisol in older adults. Biol. Psychiatry 62, 472-478. (Pubitemid 47284040)
130. Petrovitch H, White LR, Izmirilian G, Ross GW, Havlik RJ, Markesbery W, Nelson J, Davis DG, Hardman J, Foley DJ, Launer LJ (2000): Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Neurobiol. Aging 21, 57-62. (Pubitemid 30224786)
131. Potter H, Wefes IM, Nilsson LN (2001): The inflammation-induced pathological chaperones ACT and apo-E are necessary catalysts of Alzheimer amyloid formation. Neurobiol. Aging 22, 923-930. (Pubitemid 34066560)
132. Prince JA, Feuk L, Sawyer SL, Gottfries J, Ricksten A, Nägga K, Bogdanovic N, Blennow K, Brookes AJ (2001): Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease. Eur. J. Hum. Genet. 9, 437-444. (Pubitemid 32577180)
133. Qiu C, De Ronchi D, Fratiglioni L (2007): The epidemiology of the dementias: an update. Curr. Opin. Psychiatry 20, 380-385.
134. Quadri P, Fragiacomo C, Pezzati R, Zanda E, Forloni G, Tettamanti M, Lucca U (2004): Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am. J. Clin. Nutr. 80, 114-122. (Pubitemid 41115564)
135. Ramos EM, Lin MT, Larson EB, Maezawa I, Tseng LH, Edwards KL, Schellenberg GD, Hansen JA, Kukull WA, Jin LW (2006): Tumor necrosis factor alpha and interleukin 10 promoter region polymorphisms and risk of late-onset Alzheimer disease. Arch. Neurol. 63, 1165-9116. (Pubitemid 44232326)
136. Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, Gass ML, Stefanick ML, Lane DS, Hays J, Johnson KC, Coker LH, Dailey M, Bowen D (2003): Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289, 2663-2672. (Pubitemid 37430137)
137. Ravaglia G, Forti P, Maioli F, Martelli M, Servadei L, Brunetti N, Porcellini E, Licastro F (2005): Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am. J. Clin. Nutr. 82, 636-643. (Pubitemid 43759250)
138. Reed T, Carmelli D, Swan GE, Breitner JCS, Welsh K, Jarvik GP, Deeb S, Auwerx J. (1994): Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E epsilon 4 allele. Arch. Neurol. 51, 1189-1192 (Pubitemid 24369606)
139. Refolo LM, Pappolla MA, Malester B, LaFrancois J, Bryant-Thomas T, Wang R, Tint GS, Sambamurti K, Duff K (2000): Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol. Dis. 7, 321-331.
140. Retz W, Thome J, Durany N, Harsanyi A, Retz-Junginger P, Kornhuber J, Riederer P, Rosler M (2001): Potential genetic markers of sporadic Alzheimer's dementia. Psychiatr. Genet. 11, 115-122. (Pubitemid 32980610)
141. Richard F, Fromentin-David I, Ricolfi F, Ducimetiere P, Di Menza C, Amouyel P, Helbecque N (2001): The angiotensin I converting enzyme gene as a susceptibility factor for dementia. Neurology 56, 1593-1595. (Pubitemid 32532279)
142. Riemenschneider M, Schwarz S, Wagenpfeil S, Diehl J, Müller U, Förstl H, Kurz A (2002): A polymorphism of the brainderived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the Apolipoprotein E epsilon4 allele. Mol. Psychiatry 7, 782-785. (Pubitemid 34984956)
143. Riemenschneider M, Mahmoodzadeh S, Eisele T, Klopp N, Schwarz S, Wagenpfeil S, Diehl J, Mueller U, Foerstl H, Illig T, Kurz A (2004): Association analysis of genes involved in cholesterol metabolism located within the linkage region on chromosome 10 and Alzheimer's disease. Neurobiol. Aging 25, 1305-1308. (Pubitemid 39299167)
144. Rockwood K, Kirkland S, Hogan DB, MacKnight C, Merry H, Verreault R, Wolfson C, McDowell I (2002): Use of lipid-lowering agents, indication bias, and the risk of dementia in communitydwelling elderly people. Arch. Neurol. 59, 223-227. (Pubitemid 34240938)
145. Rogaeva E, Meng Y, Lee JH, Gu Y, Kawarai T, Zou F, Katayama T, Baldwin CT, Cheng R, Hasegawa H, Chen F, Shibata N, Lunetta KL, Pardossi-Piquard R, Bohm C, Wakutani Y, Cupples LA, Cuenco KT, Green RC, Pinessi L, Rainero I, Sorbi S, Bruni A, Duara R, Friedland RP, Inzelberg R, Hampe W, Bujo H, Song YQ, Andersen OM, Willnow TE, Graff-Radford N, Petersen RC, Dickson D, Der SD, Fraser PE, Schmitt-Ulms G, Younkin S, Mayeux R, Farrer LA, St George-Hyslop P (2007): The neuronal sortilinrelated receptor SORL1 is genetically associated with Alzheimer disease. Nat. Genet. 39, 168-177.
146. Roman GC, Kalaria RN (2006): Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia. Neurobiol. Aging 27, 1769-1785. (Pubitemid 44572575)
147. Russ C, Powel JF, Zhao J, Baker M, Hutton M, Crawford F, Mullan M, Roks G, Cruts M, Lovestone S (2001): The microtubule associated protein tau gene and Alzheimer's disease - an association study and meta-analysis. Neurosci. Lett. 314, 92-96. (Pubitemid 33043812)
148. Sabbatini M, Tomassoni D, Amenta F (2001): Hypertensive brain damage: comparative evaluation of protective effect of treatment with dihydropyridine derivatives in spontaneously hypertensive rats. Mech. Ageing Develop. 122, 2085-2105. (Pubitemid 32925116)
149. Salerno-Kennedy R, Cashman KD (2005): Relationship between dementia and nutrition-related factors and disorders: an overview. Int. J. Vitam. Nutr. Res. 75, 83-95. (Pubitemid 40637736)
150. Saugstad LF (2006): Are neurodegenerative disorder and psychotic manifestations avoidable brain dysfunctions with adequate dietary omega-3? Nutr. Health 18, 89-101. (Pubitemid 44018976)
151. Scacchi R, Gambina G, Broggio E, Moretto G, Ruggeri M, Corbo RM (2004): The H+ allele of the lipoprotein lipase (LPL) HindIII intronic polymorphism and the risk for sporadic lateonset Alzheimer's disease. Neurosci. Lett. 367, 177-180. (Pubitemid 39141221)
152. Schmidt R, Schmidt H, Curb JD, Masaki K, White LR, Launer LJ (2002): Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann. Neurol. 52, 168-174. (Pubitemid 34810596)
153. Selkoe DJ (2001): Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81, 741-766. (Pubitemid 32267077)
154. Seripa D, Forno GD, Matera MG, Gravina C, Margaglione M, Palermo MT, Wekstein DR, Antuono P, Davis DG, Daniele A, Masullo C, Bizzarro A, Gennarelli M, Fazio VM (2003): Methylenetetrahydrofolate reductase and angiotensin converting enzyme gene polymorphisms in two genetically and diagnostically distinct cohort of Alzheimer patients. Neurobiol. Aging 24, 933-939. (Pubitemid 36962979)
155. Seshadri S, Zornberg GL, Derby LE, Myers MW, Jick H, Drachman DA (2001): Postmenopausal estrogen replacement therapy and the risk of Alzheimer disease. Arch. Neurol. 58, 435-440. (Pubitemid 32217460)
156. Seshadri S (2006): Elevated plasma homocysteine levels: risk factor or risk marker for the development of dementia and Alzheimer's disease? J. Alzheimers Dis. 9, 393-398.
157. Shibata N, Kawarai T, Lee JH, Lee HS, Shibata E, Sato C, Liang Y, Duara R, Mayeux RP, St George-Hyslop PH, Rogaeva E. (2006): Association studies of cholesterol metabolism genes (CH25H, ABCA1 and CH24H) in Alzheimer's disease. Neurosci. Lett. 391,142-146. (Pubitemid 41736188)
158. Slifer MA, Martin ER, Bronson PG, Browning-Large C, Doraiswamy PM, Welsh-Bohmer KA, Gilbert JR, Haines JL, Pericak-Vance MA (2006): Lack of association between UBQLN1 and Alzheimer disease. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 141, 208-213.
159. Small GW, Scott WK, Komo S, Yamaoka LH, Farrer LA, Auerbach SH, Saunders AM, Roses AD, Haines JL, Pericak-Vance MA (1999): No association between the HLA-A2 allele and Alzheimer disease. Neurogenetics 2, 177-182.
160. Smemo S, Nowotny P, Hinrichs AL, Kauwe JS, Cherny S, Erickson K, Myers AJ, Kaleem M, Marlowe L, Gibson AM, Hollingworth P, O'Donovan MC, Morris CM, Holmans P, Lovestone S, Morris JC, Thal L, Li Y, Grupe A, Hardy J, Owen MJ, Williams J, Goate A (2006): Ubiquilin 1 polymorphisms are not associated with late-onset Alzheimer's disease. Ann. Neurol. 59, 21-26. (Pubitemid 43042867)
161. Sparks LD, Scheff SW, Liu H, Landers TM, Coyne CM, Hunsaker III JC (1995): Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension. J. Neurol. Sci. 131, 162-169.
162. Stellwagen D, Malenka RC (2006): Synaptic scaling mediated by glial TNF-alpha. Nature 440, 1054-1059.
163. Stern Y (2006): Cognitive reserve and Alzheimer disease. Alzheimer Dis. Assoc. Disord. 20, 112-117.
164. Strandberg TE, Pitkala KH, Linnavuori K, Tilvis RS (2004): Cognitive impairment and infectious burden in the elderly. Arch. Gerontol. Geriatr. 9, (Suppl.) 419-423. (Pubitemid 38822894)
165. Suh YH, Checler F (2002): Amyloid precursor protein, presenilins and α-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease. Pharmacol. Rev. 54, 469-525.
166. Szczygielski J, Mautes A, Steudel WI, Falkai P, Bayer TA, Wirths O (2005): Traumatic brain injury: cause or risk of Alzheimer's disease? A review of experimental studies. J. Neural Transm. 112, 1547-1564. (Pubitemid 41504269)
167. Tan ZS, Beiser AS, Vasan RS, Roubenoff R, Dinarello CA, Harris TB, Benjamin EJ, Au R, Kiel DP, Wolf PA, Seshadri S (2007): Inflammatory markers and the risk of Alzheimer disease: the Framingham Study. Neurology 68, 1902-1908. (Pubitemid 46848622)
168. Tannenberg RK, Scott HL, Tannenberg AE, Dodd PR (2006): Selective loss of synaptic proteins in Alzheimer's disease: evidence for an increased severity with APOE var epsilon4. Neurochem. Int. 49, 631-639.
169. Tarkowski E, Liljeroth AM, Nilsson A, Ricksten A, Davidsson P, Minthon L, Blennow K (2000): TNF gene polymorphism and its relation to intracerebral production of TNFalpha and TNFbeta in AD. Neurology 54, 2077-2081. (Pubitemid 30397205)
170. Taubes G (2003): Neuroscience. Insulin insults may spur Alzheimer's disease. Science 301, 40-41.
171. Tuppo EE, Arias HR (2005): The role of inflammation in Alzheimer's disease. Int. J. Biochem. Cell. Biol. 37, 289-305.
172. Tycko B, Lee JH, Ciappa A, Saxena A, Li CM, Feng L, Arriaga A, Stern Y, Lantigua R, Shachter N, Mayeux R (2004): APOE and APOC1 promoter polymorphisms and the risk of Alzheimer disease in African American and Caribbean Hispanic individuals. Arch. Neurol. 61, 1434-1439. (Pubitemid 39202227)
173. van Oijen M, Witteman JC, Hofman A, Koudstaal PJ, Breteler MM (2005): Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia. Stroke 36, 2637-2641.
174. van Oijen M, Arp PP, de Jong FJ, Hofman A, Koudstaal PJ, Uitterlinden AG, Breteler MM (2006): Polymorphisms in the interleukin 6 and transforming growth factor beta1 gene and risk of dementia. The Rotterdam Study. Neurosci. Lett. 402, 113-117. (Pubitemid 44235918)
175. Venters HD, Dantzer R, Kelley KW (2000): Tumor necrosis factoralpha induces neuronal death by silencing survival signals generated by the type I insulin-like growth factor receptor. Ann. N.Y. Acad. Sci. 917, 210-220.
176. Verreault R, Laurin D, Lindsay J, De Serres G (2001): Past exposure to vaccines and subsequent risk of Alzheimer's disease. CMAJ 165, 1495-1498. (Pubitemid 34060192)
177. Wang L, Larson EB, Bowen JD, van Belle G (2006): Performancebased physical function and future dementia in older people. Arch. Intern. Med. 166, 1115-1120. (Pubitemid 43765183)
178. Wang F, Jia J (2007): Polymorphisms of cholesterol metabolism genes CYP46 and ABCA1 and the risk of sporadic Alzheimer's disease in Chinese. Brain Res. 1147, 34-38. (Pubitemid 46574561)
179. Watson GS, Craft S (2003): The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment. CNS drugs 17, 27-45. (Pubitemid 36044347)
180. Watson GS, Bernhardt T, Reger MA, Cholerton BA, Baker LD, Peskind ER, Asthana S, Plymate SR, Frolich L, Craft S (2006): Insulin effects on CSF norepinephrine and cognition in Alzheimer's disease. Neurobiol. Aging 27, 38-41. (Pubitemid 41627948)
181. Webber KM, Casadesus G, Perry G, Atwood CS, Bowen R, Smith MA (2005): Gender differences in Alzheimer's disease: the role of luteinizing hormone in disease pathogenesis. Alzheimer. Dis. Assoc. Disord. 19, 95-99. (Pubitemid 41073087)
182. Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry Jr CP, Yaffe K (2005): Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ 330, 1360. (Pubitemid 40839562)
183. Wilson RS, Arnold SE, Schneider JA, Kelly JF, Tang Y, Bennett DA (2006): Chronic psychological distress and risk of Alzheimer's disease in old age. Neuroepidemiology 27, 143-153. (Pubitemid 44651434)
184. Wilson RS, Krueger KR, Arnold SE, Schneider JA, Kelly JF, Barnes LL, Tang Y, Bennett DA (2007): Loneliness and risk of Alzheimer disease. Arch. Gen. Psychiatry 64, 234-240.
185. Wischik CM, Novák M, Thøgersen HC, Edwards PC, Runswick MJ, Jakes R, Walker JE, Milstein C, Roth M, Klug A (1988): Isolation of a fragment of tau derived from the core of paired helical filament of Alzheimer's disease, Proc. Natl. Acad. Sci. USA 85, 4506-4510. (Pubitemid 18177785)
186. Wolozin B, Kellman W, Ruosseau P, Celesia GG, Siegel G (2000): Decreased Prevalence of Alzheimer Disease Associated With 3-Hydroxy-3-Methyglutaryl Coenzyme A Reductase Inhibitors. Arch. Neurol. 57, 1439-1443. (Pubitemid 30769120)
187. Zandi PP, Breitner JC (2001): Do NSAIDs prevent Alzheimer's disease? And, if so, why? The epidemiological evidence. Neurobiol. Aging 22, 811-817.
188. Zhou B, Teramukai S, Fukushima M (2007): Prevention and treatment of dementia or Alzheimer's disease by statins: a meta-analysis. Dement. Geriatr. Cogn. Disord. 23,194-201. (Pubitemid 46333787)
189. Žilka N, Ferenčík M, Hulín I (2006): Neuroinflammation in Alzheimer's disease: protector or promoter? Bratisl. Med. J. 107, 374-383.
190. Zonderman AB (2005): Predicting Alzheimer's disease in the Baltimore Longitudinal Study of Aging. J. Geriatr. Psychiatry Neurol. 18, 192-195. (Pubitemid 41736382)